NCT02735551

Brief Summary

This prospective randomized controlled study will evaluate if Long Acting Reversible Contraceptive (LARC) forward counseling in combination with same-day LARC placement increases overall LARC uptake within a community college population compared to LARC forward counseling and referral to a secondary clinic for LARC placement. The study will be conducted at Mount Hood Community College (MHCC) in Oregon. Participants will be enrolled into three groups. All groups will receive the same standardized contraceptive counseling ("LARC forward counseling") and participants will be able to choose between a LARC method and short-acting method of birth control.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Apr 2016

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 6, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 12, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2017

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2017

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

January 3, 2019

Completed
Last Updated

November 12, 2019

Status Verified

October 1, 2019

Enrollment Period

12 months

First QC Date

April 6, 2016

Results QC Date

September 21, 2018

Last Update Submit

October 28, 2019

Conditions

Keywords

LARCIUDContraceptive ImplantContraceptionCommunity college

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Reporting Ongoing Use and Satisfaction

    Proportion of Long Acting Reversible Contraception (LARC) uptake among women, by group assignment. This will be evaluated based on participants' self-reported ongoing use and satisfaction by group assignment on the 3-month questionnaire after the initial visit. 3 months following placement of LARC device, initiation of short acting method, and those in the control group, participants will complete a questionnaire in order to assess ongoing use and satisfaction of their contraceptive method. This will be measured on the 3-month questionnaire.

    3 months

Study Arms (3)

Non-LARC Group: Short Acting Method

ACTIVE COMPARATOR

All groups will receive the same standardized contraceptive counseling ("LARC forward counseling"). Participants who chose a short-acting hormonal method (e.g. contraceptive pills, ring, or patch) will receive a prescription to the pharmacy of their choice, as is the current practice for students who present for contraceptive services

Other: Prescription for Short-Acting Hormonal Contraception

Control Group: Referral for LARC Placement

ACTIVE COMPARATOR

All groups will receive the same standardized contraceptive counseling ("LARC forward counseling"). Randomized to referral for LARC placement to local clinic.

Other: Referral for Long Acting Reversible Contraception (LARC)

LARC Group: Same Day LARC Placement

ACTIVE COMPARATOR

All groups will receive the same standardized contraceptive counseling ("LARC forward counseling"). Randomized to same day LARC placement (intervention).

Drug: Long Acting Reversible Contraception (LARC)

Interventions

Same day LARC placement (intervention) of Mirena, Skyla, Paragard, Implanon

LARC Group: Same Day LARC Placement

Referral to local clinic for LARC placement of choice (Mirena, Skyla, Paragard, Implanon, etc.)

Control Group: Referral for LARC Placement

Participants who chose a short-acting hormonal method (e.g. contraceptive pills, ring, or patch) will receive a prescription to the pharmacy of their choice

Non-LARC Group: Short Acting Method

Eligibility Criteria

Age17 Years - 30 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • English or Spanish-speaking women.
  • years of age.
  • Currently enrolled in a 2-year certificate program at Mount Hood Community College.
  • At risk for pregnancy (sexually active with men or anticipate becoming sexually active in the next 6 months).
  • Do not desire pregnancy within the next 12 months.
  • No contraindications to LARC according to the Center for Disease Control and Prevention medical eligibility criteria (CDC MEC)

You may not qualify if:

  • Women who are not currently sexually active with men and who do not anticipate becoming sexually active with a male partner in the next 6 months.
  • Women who have had a tubal ligation or other sterilization procedure.
  • Women who desire pregnancy within the next 12 months.
  • Women currently already using a LARC method for contraception.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Hood Community College

Gresham, Oregon, 97030, United States

Location

Related Publications (1)

  • Lamme J, Edelman A, Padua E, Jensen JT. Evaluation of the challenges faced in increasing contraceptive access within a community college population. Contracept Reprod Med. 2017 Oct 23;2:25. doi: 10.1186/s40834-017-0051-8. eCollection 2017.

MeSH Terms

Interventions

Long-Acting Reversible ContraceptionReferral and ConsultationPrescriptions

Intervention Hierarchy (Ancestors)

ContraceptionReproductive TechniquesTherapeuticsProfessional PracticeOrganization and AdministrationHealth Services AdministrationPharmaceutical ServicesHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Ob/Gyn Regulatory Specialist
Organization
Oregon Health & Science University

Study Officials

  • Jacqueline Lamme, MD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Instructor

Study Record Dates

First Submitted

April 6, 2016

First Posted

April 12, 2016

Study Start

April 1, 2016

Primary Completion

March 13, 2017

Study Completion

March 31, 2017

Last Updated

November 12, 2019

Results First Posted

January 3, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations